VNB
AGN

Virginia National Bank’s Allergan plc AGN Stock Holding History

Virginia National Bank’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,120
Closed -$375K – 26
2020
Q1 		$375K Hold
2,120
– – 6.08% 3
2019
Q4 		$405K Hold
2,120
– – 0.36% 47
2019
Q3 		$357K Hold
2,120
– – 0.29% 49
2019
Q2 		$355K Hold
2,120
– – 0.27% 51
2019
Q1 		$310K Sell
2,120
-1,296
-38% -$188K 0.21% 56
2018
Q4 		$457K Hold
3,416
– – 0.34% 43
2018
Q3 		$651K Buy
+3,416
New +$628K 0.24% 42

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Virginia National Bank's AGN Position: Q2 2020 in Review

Virginia National Bank sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,120 shares — an estimated $375K sold.

Virginia National Bank first reported a position in AGN in Q3 2018 and held it in 7 quarters. The position peaked at $651K in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Virginia National Bank reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Virginia National Bank sold 2,120 Allergan plc shares in Q2 2020, an estimated $375K.
  • Virginia National Bank first reported a position in Allergan plc in Q3 2018 and held it in 7 quarters.
  • Virginia National Bank's Allergan plc position peaked at $651K in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Virginia National Bank's 13F filing for Q2 2020, filed 8 Jul 2020.